BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lyons AB, Peacock A, McKenzie SA, Jacobsen G, Naik HB, Shi VY, Hamzavi IH, Hsiao JL. Evaluation of Hidradenitis Suppurativa Disease Course During Pregnancy and Postpartum. JAMA Dermatol 2020;156:681-5. [PMID: 32347884 DOI: 10.1001/jamadermatol.2020.0777] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Repetto F, Burzi L, Ramondetta A, Rozzo G, Licciardello M, Ribero S, Quaglino P, Dapavo P. Certolizumab pegol and its role in pregnancy-age hidradenitis suppurativa. Int J Dermatol 2021. [PMID: 34270087 DOI: 10.1111/ijd.15742] [Reference Citation Analysis]
2 Althagafi H, Spence AR, Czuzoj-shulman N, Abenhaim HA. Effect of hidradenitis suppurativa on obstetric and neonatal outcomes. The Journal of Maternal-Fetal & Neonatal Medicine. [DOI: 10.1080/14767058.2021.1974833] [Reference Citation Analysis]
3 Montero-Vilchez T, Salvador-Rodriguez L, Rodriguez-Tejero A, Sanchez-Diaz M, Arias-Santiago S, Molina-Leyva A. Reproductive Potential and Outcomes in Patients with Hidradenitis Suppurativa: Clinical Profile and Therapeutic Implications. Life (Basel) 2021;11:277. [PMID: 33810294 DOI: 10.3390/life11040277] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Narla S, Lyons AB, Hamzavi IH. The most recent advances in understanding and managing hidradenitis suppurativa. F1000Res 2020;9:F1000 Faculty Rev-1049. [PMID: 32884675 DOI: 10.12688/f1000research.26083.1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
5 Prens LM, Porter ML, Savage KT, Salian P, Horváth B, Kimball AB. Hidradenitis suppurativa disease course during pregnancy and postpartum: a retrospective survey study. Br J Dermatol 2021;185:1072-4. [PMID: 33760224 DOI: 10.1111/bjd.20078] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Collier EK, Seivright JR, Shi VY, Hsiao JL. Pregnancy and breastfeeding in hidradenitis suppurativa: A review of medication safety. Dermatol Ther 2021;34:e14674. [PMID: 33320387 DOI: 10.1111/dth.14674] [Reference Citation Analysis]
7 Sayed CJ, Hsiao JL, Okun MM; Hidradenitis Suppurativa Foundation Women's Health Subcommittee. Clinical Epidemiology and Management of Hidradenitis Suppurativa. Obstet Gynecol 2021;137:731-46. [PMID: 33706337 DOI: 10.1097/AOG.0000000000004321] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Ferrer-Alcala MA, Sánchez-Díaz M, Arias-Santiago S, Molina-Leyva A. Impact of Psoriasis and Hidradenitis Suppurativa in Pregnancy, a Systematic Review. J Clin Med 2021;10:5894. [PMID: 34945189 DOI: 10.3390/jcm10245894] [Reference Citation Analysis]
9 Sakya SM, Hallan DR, Maczuga SA, Kirby JS. Outcomes of pregnancy and childbirth in women with hidradenitis suppurativa. J Am Acad Dermatol 2021:S0190-9622(21)01984-8. [PMID: 34153386 DOI: 10.1016/j.jaad.2021.05.059] [Reference Citation Analysis]